Two Sigma Advisers
SWTX

Two Sigma Advisers’s SpringWorks Therapeutics SWTX Stock Holding History

Two Sigma Advisers’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-24,500
Closed -$785K – 2526
2024
Q3 		$785K Sell
24,500
-17,500
-42% -$654K ﹤0.01% 1521
2024
Q2 		$1.58M Buy
+42,000
New +$1.77M ﹤0.01% 1318
2023
Q4 		– Sell
-12,400
Closed -$287K – 2639
2023
Q3 		$287K Sell
12,400
-17,200
-58% -$470K ﹤0.01% 1994
2023
Q2 		$776K Sell
29,600
-67,200
-69% -$1.77M ﹤0.01% 1636
2023
Q1 		$2.49M Sell
96,800
-57,900
-37% -$1.69M 0.01% 1163
2022
Q4 		$4.02M Buy
154,700
+1,700
+1% +$41.9K 0.01% 871
2022
Q3 		$4.37M Buy
153,000
+4,600
+3% +$132K 0.01% 800
2022
Q2 		$3.65M Buy
+148,400
New +$5.43M 0.01% 902
2022
Q1 		– Sell
-34,000
Closed -$2.11M – 2894
2021
Q4 		$2.11M Buy
34,000
+3,200
+10% +$212K 0.01% 1169
2021
Q3 		$1.95M Buy
30,800
+25,500
+481% +$1.96M 0.01% 1273
2021
Q2 		$437K Sell
5,300
-8,900
-63% -$676K ﹤0.01% 1995
2021
Q1 		$1.04M Buy
+14,200
New +$1.11M ﹤0.01% 1629

Other funds holding SWTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Two Sigma Advisers's SWTX Position: Q4 2024 in Review

Two Sigma Advisers sold out of SpringWorks Therapeutics (SWTX) in Q4 2024, closing a stake of 24,500 shares — an estimated $785K sold.

Two Sigma Advisers first reported a position in SWTX in Q1 2021 and held it in 12 quarters. The position peaked at $4.37M in Q3 2022. 216 funds tracked by Wall St. Rank hold SWTX as of Q4 2024.

  • Two Sigma Advisers reported no remaining SpringWorks Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Two Sigma Advisers sold 24,500 SpringWorks Therapeutics shares in Q4 2024, an estimated $785K.
  • Two Sigma Advisers first reported a position in SpringWorks Therapeutics in Q1 2021 and held it in 12 quarters.
  • Two Sigma Advisers's SpringWorks Therapeutics position peaked at $4.37M in Q3 2022.
  • 216 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q4 2024.

Based on Two Sigma Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.